Early Detection Research Network


This biomarker is also known as:
  • H2BFH,
  • Histone H2B.A,
  • Histone H2B.L,
  • Histone H2B.1 A,
  • H2B/h,
  • dJ221C16.8,
  • H2B/a,
  • HIST1H2BG,
  • H2B/g,
  • H2BFL,
  • H2B/k,
  • Histone H2B.K,
  • H2B.1A,
  • Histone Cluster 1, H2bg,
  • H2BFK,
  • Histone H2B.H,
  • H2B Histone Family, Member A,
  • Histone 1, H2bg,
  • H2BFG,
  • Histone H2B.G,
  • Histone H2B Type 1-C/E/F/G/I,
  • H2BFA,
  • H2B/l,


histone cluster 1, H2bg


There are no datasets associated with this biomarker.

QA State: Curated
Type: Gene

The following organs have data associated with this biomarker…


Phase: One
QA State: Curated


No additional prostate data available.

Performance Comment

Significance Analysis of Microarray (SAM) was used to develop a 7-gene classifier. The overall prediction accuracy and sensitivity is 71% and 76%, respectively. The inclusion of the Gleason sum to the seven-gene classifier raised the prediction accuracy and sensitivity to 83% and 76% respectively This prognostic signature is closely associated with biochemical recurrence in patients after radical prostatectomy. The seven genes are: RRAGD, PQBP1, HIST1H2BC, ALDH1A2, TRIM22, RBPMS, HSPB8.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.